Effects of the intensity of downregulation on outcome of in vitro fertilization and embryo transfer

References

• Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod 1986;1:81–7
   PubMed Web of Science ®Google Scholar
• Ryan KJ, Petro Z. Steroid biosynthesis by human ovarian granulose and thecal cells. J Clin Endocrinol Metab 1966;26:46–52
   PubMed Web of Science ®Google Scholar
• Ryan KJ, Petro Z, Kaiser J. Steroid formation by isolated and recombined ovarian granulose and thecal cells. J Clin Endocrinol Metab 1968;28:355–8
   Google Scholar
• Lawrence TS, Dekel N, Beers WH. Binding of human chorionic gonadotrophin by rat cumuli oophori and granulose cells: a comparative study. Endocrinology 1980;106:1114–18
   Google Scholar
• Espey LL. Ovarian proteolytic enzymes and ovula-tion. Biol Reprod 1974;10:216–35
   Google Scholar
• Kamitis VJ, Townson DH, Friedman CI, Danforth DR. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadtrophin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroido genesis. J Clin Endocrinol Metab 1994;79:91–7
   Google Scholar
• Winter JS, Faiman C, Hobson WC, et al. Pituitary-gonadal relations in infancy. I. Patterns of serum gonadotropin concentrations from birth to four years of age in man and chimpanzee. J Clin Endocrinol Metab 1975;40:545–51
   Google Scholar
• Zhuang LZ, Adashi EY, Hsuch AJ. Direct enhancement of gonadotropin-stimulated ovarian estrogen biosynthesis by estrogen and clomiphene citrate. Endocrinology 1982;110:2219–21
   Google Scholar
• Shoham Z, Schachter M. Estrogen biosynthesis-regulation, action, remote effects, and value of monitoring in ovarian stimulation cycles. Fertil Steril 1996;65:687–701
   PubMed Web of Science ®Google Scholar
• Shoham Z, Balen A, Patel A, et al. Results o f ovula-tion induction using hMG or purified FSH in hyp o go nado trophic hypogonadism patients. Fertil Steril 1991;56:1048–53
   PubMed Web of Science ®Google Scholar
• Schoot DC, Coelingh Bennink HJT, Mannaerts BMJL, et al. Human recombinant FSH induces growth of preovulatory follicles without concomi-tant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency. J Clin Endocrinol Metab 1992;74:1471–3
   PubMed Web of Science ®Google Scholar
• Balasch J, Miro F, Burzaco I, et al. The role ofLH in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human FSH. Hum Reprod 1995;10:1678–83
   PubMed Web of Science ®Google Scholar
• Fleming R, Lloyd F, Herbert M, et al. Effects of profound suppression of LH during ovarian stimu-lation of follicular activity, oocyte and embryo function in cycles stimulated with purified FSH. Hum Reprod 1998;13:1788–92
   PubMed Web of Science ®Google Scholar
• Kousta E, White DM, Piazzi A, et al. Successful induction of ovulation and completed pregnancy using recombinant LH and FSH in a woman with Kallman's syndrome. Hum Reprod 1996;11:70–1
   PubMed Web of Science ®Google Scholar
• Schoot DC, Harlin J, Shoham Z, et al. Blastocyst culture and transfer: analysis of results and para-meters affecting outcome in two in vitro fertilization programs. Fertil Steril 1999;72:604–9
   Google Scholar
• Palermo GD, Alikani M, Bertoli M, et al. Oolemma characteristics in relation to survival and fertilization patterns of oocytes treated by intra-cytoplasmic sperm injection. Hum Reprod 1996;11: 172–6
   Google Scholar
• Rabinovici J, Blankstein J, Goldman B, et al. In vitro fertilization and primary embryonic cleavage are possible in 1713-estradiol. J Clin Endocrinol Metab 1989;68:693–7
   PubMed Web of Science ®Google Scholar
• Westergaard LG, Laursen SB Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod 2000;15:1003–8
   PubMed Web of Science ®Google Scholar
• Waldstreicher J, Santoro NF, Hall JE, et al. Hyper-function of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab 1988;66:165–72
   PubMed Web of Science ®Google Scholar
• Shoham Z, Jacobs HS, Insler V. Luteinizing hor-mone: its role, mechanism of action, and detrimen-tal effects when hypersecreted during the follicular phase. Fertil Steril 1993;59:1153–61
   Google Scholar
• Chappel SC, Howles C. Re-evaluation of the roles of LH and FSH in the ovulatory process. Hum Reprod 1991;6:1206–12
   PubMed Web of Science ®Google Scholar
• Uilenbroek JT, Woutersen PJ, Van-der-Schoot P. Atresia of preovulatory follicles: gonadotrophin binding and steroidogenic activity. Biol Reprod 1980;23:219–29
   Google Scholar
• Yoshimura Y, Wallach EE. Studies of the mecha-nisms of mammalian ovulation. Fertil Steril 1993; 59:54–9
   Google Scholar
• Balen AH, Tan SL, MacDougall J, Jacobs HS. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod 1993;8:959–64
   PubMed Web of Science ®Google Scholar
• Filicori M. Clinical review 81: gonadotrophin-releasing hormone analogs in ovulation induction: current status and perspectives. J Clin Endocrinol Metab 1996;81:2413–16
   PubMed Web of Science ®Google Scholar
• Filicori M. The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertil Steril 1999;71:405–14
   PubMed Web of Science ®Google Scholar
• Strehler E, Abt M, El-Danasouri I, et al. Impact of recombinant FSH and hMG on in vitro fertilization outcome. Fertil Steril 2001;75:332–6
   PubMed Web of Science ®Google Scholar
• Westergaard LG, Erb K, Laursen SB, et al. Human menopausal gonadotropin versus recombinant FSHin no rmogo nadotropic women down-regulated with a GnRH agonist who were under-going in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study. Fertil Steril 2001;76:543–9
   PubMed Web of Science ®Google Scholar
• Balasch J, Vidal E, Penarrubia J, et al. Suppression of LH during ovarian stimulation: analyzing threshold values and effects on ovarian response and the out-come of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod 2001;16:1636–43
   PubMed Web of Science ®Google Scholar
• Rekha P, Mowat L, Jamieson ME, et al. Effect of profound suppression of luteinizing hormone during treatment with gonadotrophin releasing hormone analogue and purified follicle stimulating hormone upon development of cryopreserved embryos. Hum Reprod 1998;13:696–8
   Google Scholar
• Lockwood GM, Muttukrishna S, Groome NP, et al. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer. Clin En do-crinol 1996;45:741–8
   Google Scholar
• Duijkers IJ, Magnusson YM, Hollanders HM. Serum levels of FSH and LH after subcutaneous administration of hMG during pituitary suppres-sion. IntJ Feral Menopausal Studies 1995;40:307–10
   Google Scholar